abstract |
This invention relates to active compounds, pharmaceutical compositions and methods for the treatment of androgen-mediated diseases, and the specified composition contains new inhibitors of testosterone 5D reductase activity. Inhibitors have a good combination of inhibitory action on 5-reductase activity, low or no androgenic activity, and, in some embodiments, antiandrogenic activity. |